1-6 of 6
Arthur Burnett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Controlled Double Blind Feasibility Trial of Tadalafil with Hydroxyurea Versus Hydroxyurea with Placebo for Secondary Prevention of Recurrent Priapism in Men with Sickle Cell Anemia: Pin Trial Final Results

Ibrahim Musa Idris, Aminu Abba Yusuf, Ismail Ismail, Awwal Musa Borodo, Kabiru Musangedu, Tukur Aliyu, Datti Alfa, Mustapha Shuaiabu Hikima, Mohammad Suwaid, Shehu Kana, Sani Aji, Aisha Kuliya Gwarzo, Kabiru Bello Muhammad, Jamil Aliyu Galadanci, Rukayya Alkassim, Nafiu Hussaini, Mark Rodeghier, Arthur Burnett, Michael R. DeBaun
Journal: Blood
Blood (2023) 142 (Supplement 1): 2531.
https://doi.org/10.1182/blood-2023-190396
Published: 2023
Journal Articles

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Modupe Idowu, Michael R. DeBaun, Arthur Burnett, Deepika S. Darbari, Soheir Adam, Alan Randall Anderson, Julie Kanter, Henny H. Billett, Darla K. Liles, Robert S. Nickel, Laura M. Decastro, Biree Andemariam, Gershwin Theophilus Blyden, Matthew M. Heeney, Poornima Ramadas, Morgan L. McLemore, Yogita Kolekar, Dramane Laine, Jincy Paulose, Rajendra Sarkar, Mary Beth Vignogna, Fuad El Rassi
Journal: Blood
Blood (2023) 142 (Supplement 1): 146.
https://doi.org/10.1182/blood-2023-179042
Published: 2023
Journal Articles

Pediatric Hydroxyurea Treatment Patterns, Sickle Cell Disease-Related Complication Rates, and Costs in a Large US Administrative Claims Database: A Retrospective Analysis

Deepa Manwani, Arthur Burnett, Jincy Paulose, Glorian P. Yen, Tanya Burton, Amy Anderson, Sara Wang, Soyon Lee, Santosh L. Saraf
Journal: Blood
Blood (2021) 138 (Supplement 1): 4055.
https://doi.org/10.1182/blood-2021-147956
Published: 2021
Journal Articles

Cross Sectional Survey of Priapism and Sexual Dysfunction in 353 Men with Sickle Cell Disease

Ibrahim Musa Idris, MBBS,MPH, Jamil Aliyu Galadanci, Msc, Akib Abba, MBBS, Sharfuddeen Abbas Mashi, MBBS FWACS, Anele Uzoma, MD, Kemberlee R Bonnet, M.A, David G Schlundt, PhD, Nafiu Hussain, PhD, Arthur Burnett, MD MBA, Michael R. DeBaun, MDMPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 2302.
https://doi.org/10.1182/blood-2019-128825
Published: 2019
Journal Articles

A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Priapism (SPARTAN)

Fuad A El Rassi, MD, Deepika S. Darbari, MD, Arthur Burnett, MD MBA, Jincy Paulose, MD, Dramane I Laine, Das Purkayastha, PhD, Gregory J Kato, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1007.
https://doi.org/10.1182/blood-2019-125790
Published: 2019
Journal Articles

A Systematic Literature Review of the Burden of Ischemic Priapism in Patients with Sickle Cell Disease

Dave Nellesen, PhD, Sedge Lucas, BA, Che-Rung Liu, MA., Menaka Bhor, PhD, Jincy Paulose, MD, Arthur Burnett, MD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 3467.
https://doi.org/10.1182/blood-2019-128951
Published: 2019